Announced Mon, 21 Sept · 15:22 IST
Max-Bio Biosciences acquires 11.89% in Raconteur via preferential allotment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Max-Bio Biosciences Pvt Ltd acquired 21,42,857 shares (11.89%) of Raconteur Global Resources via preferential allotment on 8 Sep 2026. The acquirer is not part of the promoter group. Before acquisition it held zero shares; after, it holds 11.89%. Filing is under Reg 29(1) of SEBI Takeover Regulations as the acquirer crossed the 10 percent shareholding threshold. Raconteur total equity capital rose to 18,02,78,420 shares post allotment.
Likely market impact
Non-promoter crossing 10 percent signals strategic interest or stake buildup. Preferential allotment dilutes existing shareholders.